Gilead to Pay $1.3B for Oral Peptide That Could Rival J&J’s New Immunology Pill
Gilead Sciences is getting world rights to an experimental PepStar Therapeutics oral peptide designed to inhibit the IL-23 receptor to ...
Tag: Immunology
Immunology Startup ai3Bio Aims to Redefine What It Means to Reset the Immune System
Whereas the immune reset area is principally centered on depleting pathogenic B cells, ai3Bio is making use of its novel ...
Processa Acquisition Lands Immunology Drug That Could Rival a New Novartis Product
With the merger, Processa’s new lead asset is a Vidya Therapeutics immunology drug that provides pipeline-in-a-product potential addressing a goal ...
After Antibiotic Approval, Spero Pivots to Immunology Aiming to Rival an Amgen Asset
Spero Therapeutics enters immunology with an antibody licensed from Innovent Biologics. The lead indication is a uncommon autoimmune situation the ...
Odyssey’s IPO Brings In $304M for Quest to Develop Better Immunology Drugs
Ulcerative colitis is the lead indication for Odyssey Therapeutics’ internally found lead drug candidate. With the IPO proceeds, Odyssey plans ...
Taking a Page From Cancer Drugs, Autoimmune Biotech Alumis Aims for Precision Immunology
Alumis’s genomic analysis guided its improvement of envudeucitinib, a TYK2 inhibitor that some analysts now view as greatest at school. ...
Boehringer Boosts Pipeline, Adding Oral Small Molecules With Broad Immunology & Inflammation Potential
Boehringer Ingelheim receives rights to oral small molecules from Sitryx with potential purposes in a number of autoimmune issues. Relying ...
Eli Lilly Boosts Its Immunology Drug Pipeline With $1.2B Ventyx Bio Acquisition
Eli Lilly is building its prospects in immunology through the $1.2 billion acquisition of Ventyx Biosciences, a clinical-stage company with ...
AbbVie’s $2.1B Acquisition Adds In Vivo Cell Therapy to Its Immunology & Inflammation Pipeline
AbbVie wasn’t part of the first wave of cell therapies developed for cancer, but it is positioning itself to contend ...
3 Biotech IPOs, $703M Raised for Clinical Trials in Cancer, Immunology & Endocrine Disorders
Cancers of the head and neck can be treated with several drugs on the market, but for certain patients diagnosed ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!